Navigation Links
Preimplantation Genetic Diagnosis (PGD) Market is Expected to Reach USD 47.4 Million Globally in 2018: Transparency Market Research

ALBANY, New York, October 29, 2012 /PRNewswire/ --

According to the latest market report published by Transparency Market Research ( "Preimplantation Genetic Diagnosis (PGD) Market - Global Industry Analysis, Market Size, Market Share & Forecast 2012 - 2018," the global pre-implantation genetic diagnosis market was estimated to be worth USD 31.9 million in 2011 and is expected to reach USD 47.4 million in 2018, growing at a CAGR of 6.2% from 2013 to 2018. North America dominates the global demand for PGD, and is expected to account for over 30% of the global market followed by Europe at 28% in 2018.

Browse the full report at 

Some of the major drivers of the global PGD market are increase in the scope of direct to consumer genetic testing methods, increase in the number of cases of genetic diseases, the rising rate of infertility and the efficiency of PGD in assisting successful fetal implantation.  PGD is adjunct to in vitro fertilization (IVF) and is employed for detection of any genetic abnormality in the embryo before it is implanted through IVF.

The major types of PGD testing are for determination of chromosomal abnormalities, detection of aneuploidy, HLA typing, gender selection and others. The major market for PGD exists in developed countries. However, emerging markets in the developing nations of Asia and rest of the world will grow with the advent of genetic diagnosis technology and awareness about prevention of genetic disorders.

Over the last decade, the demand for PGD has grown significantly, mostly owing to the growing awareness regarding the prevention of genetic diseases and the increase in the number of genetic disorders which can be diagnosed through PGD. Major opportunities which can be tapped for inducing further growth of the PGD market are innovations in the field of diagnosis of genetically inherited cancer and innovations in genetic diagnosis.

Related & Recently Published Reports by Transparency Market Research

Prostate Cancer Market

Global Osteoporosis Market

Global Nutraceuticals Product Market

Global Nutraceuticals Ingredients Market

Global Surgical Equipment Industry

COPD Drugs Industry

Global Spectrometry Industry

Circulating Tumor Cells Market

Synthetic Biology Industry

U.S. Vaccine Industry

Insulin Devices Market

Home Health Care Industry

Ecc Procedures Industry

The prime geographical markets for PGD are Europe and North America. It is expected that North America will lead the PGD market in terms of market share and revenue by 2018. Asia and rest of the world will also grow at a fast yet steady pace and make their mark in the global PGD market.

This research is specially designed to estimate and analyze the demand for preimplantation genetic diagnosis in the global market. The research provides in-depth analysis of preimplantation genetic diagnosis service providers, the product sales, segment wise trend analysis and the demand of PGD by geography. High level analysis of the segments of the global PGD market is performed and the report provides detailed analysis, comprehensive historical data and statistically tested forecast of the segments thus covered. A comprehensive assessment of the strategies of the participants of the market and the winning imperatives for them has been analyzed by segmenting the global preimplantation genetic diagnosis market as below:

Preimplantation genetic diagnosis market by product types

- For determination of chromosomal abnormalities

- Aneuploidy

- HLA typing

- Gender selection

- X-linked diseases

- Single gene disorders

- Other genetic disorders


Preimplantation genetic diagnosis market by application

- Determination of HLA compatible embryos for stem cell therapy

- Late-onset genetic disorders

- Improving prognosis for in vitro fertilization patients

- Inherited genetic diseases

- Others

In addition a detailed cross sectional analysis of the above segments with respect to the following geographical markets has been performed:

- North America

- Europe

- Asia

- Rest of the World (RoW)

Browse all Pharmaceutical Market Research Reports

Upcoming Reports in Pharmaceutical Market

Membrane Bioreactor (MBR) Market

Smart Pill Technology Market

Biosimulation Market

Bioinformatics Market

Neuromodulation Devices Market

Hormone Replacement Therapy Market

Agricultural Biotechnology Market

Acute Myeloid Leukemia (AML) Therapeutics Market

Freeze Drying Equipment Market

Antibiotic Market

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Search Reports: 

SOURCE Transparency Market Research
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Interleukin Genetics Reports Third Quarter 2011 Financial Results
2. Members of Congress, Cancer Experts Address Impact of Genetic Testing on Cancer
3. Metamark Genetics Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech
4. Ambry Genetics Launches Illumina MiSeq Next-Gen Sequencing Services
5. Cytogenetics - Technologies, Markets and Companies
6. 23andMe Presents Top Ten Most Interesting Genetic Findings of 2011
7. India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
8. deCODE Genetics, in Collaboration with Academic Colleagues, Discovers Three Variants in the Sequence of the Human Genome that Affect the Risk of Thyroid Cancer
9. GeneThera, Inc. Acquires Applied Genetics, S.A.
10. Genetics Policy Institute (GPI) Files Additional Legal Arguments in Sherley v. Sebelius Stem Cell Case
11. Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team
Post Your Comments:
(Date:11/24/2015)... NEW YORK , November 24, 2015 ... in a European healthcare ... in which the companies will work closely together in identifying ... of unmet medical need. The collaboration is underpinned by a ... LSP fund. This is the first investment by Bristol-Myers Squibb ...
(Date:11/23/2015)... with a certain type of lung nodule visible on lung ... cancer than men with similar nodules, according to a new ... the Radiological Society of North America ... Lung nodules are small masses of tissue in the lungs ... appearance on CT. Solid nodules are dense, and they obscure ...
(Date:11/23/2015)... Columbia, Md. (PRWEB) , ... November 23, 2015 ... ... R&D 100 award for the development of its Nexera UC Unified Chromatography system. ... the 100 most technically significant new products of the year in the analytical ...
(Date:11/23/2015)... PISCATAWAY, New Jersey , November 23, ... Centre (CCDC) announces the launch of the ... and the CSD-System, now complemented by three powerful ... support the discovery of new molecules, CSD-Materials for ... complete set of the CCDC,s applications incorporating CSD-Discovery ...
Breaking Biology Technology:
(Date:10/29/2015)... Va. , Oct. 29, 2015 Daon, ... today that it has released a new version of ... customers in North America have ... IdentityX v4.0 also includes a FIDO UAF certified ... are already preparing to activate FIDO features. These customers ...
(Date:10/29/2015)... Oct. 29, 2015  Connected health pioneer, Joseph ... explosion of technology-enabled health and wellness, and the business ... The Internet of Healthy Things . ... smartphones even existed, Dr. Kvedar, vice president, Connected Health, ... care delivery, moving care from the hospital or doctor,s ...
(Date:10/29/2015)... 29, 2015 Today, LifeBEAM , ... with 2XU, a global leader in technical performance ... hat with advanced bio-sensing technology. The hat will ... monitor key biometrics to improve overall training performance. ... two companies will bring together the most advanced technology, ...
Breaking Biology News(10 mins):